From February 2, 2024 to March 31, 2024, the company has repurchased 11,668,812 shares, representing 0.84% for CNY 84.62 million. With this, the company has completed the repurchase of 11,668,812 shares, representing 0.84% for CNY 84.62 million under the buyback announced on February 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.23 CNY | -4.94% | -10.95% | -47.84% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-47.84% | 845M | |
+43.31% | 6.19B | |
-16.99% | 4.48B | |
+6.39% | 3.29B | |
-13.10% | 3.12B | |
-4.17% | 2.5B | |
+45.47% | 1.94B | |
-9.11% | 1.68B | |
-2.09% | 1.64B | |
-12.50% | 1.56B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.